Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X7IZ
|
|||
| Former ID |
DNC002810
|
|||
| Drug Name |
N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea
|
|||
| Synonyms |
N-BENZOYL-N'-BETA-D-GLUCOPYRANOSYL UREA; CHEMBL489799; BZD; 2qnb; DB04295; AC1L9JVC; SCHEMBL4311564; 1k08; 1k06; BDBM50263771; 1-(beta-D-Glucopyranosyl)-3-benzoylurea; N-BENZOYL-N''-BETA-D-GLUCOPYRANOSYL UREA; N-[(phenylcarbonyl)carbamoyl]-beta-D-glucopyranosylamine; N-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl]benzamide; N-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-ylcarbamoyl)benzamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H18N2O7
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C(=O)NC(=O)NC2C(C(C(C(O2)CO)O)O)O
|
|||
| InChI |
1S/C14H18N2O7/c17-6-8-9(18)10(19)11(20)13(23-8)16-14(22)15-12(21)7-4-2-1-3-5-7/h1-5,8-11,13,17-20H,6H2,(H2,15,16,21,22)/t8-,9-,10+,11-,13-/m1/s1
|
|||
| InChIKey |
JSBCZGSPFATCOV-BZNQNGANSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glycogen phosphorylase muscle form (GP) | Target Info | Inhibitor | [1] |
| BioCyc | Glycogenolysis | |||
| KEGG Pathway | Starch and sucrose metabolism | |||
| Metabolic pathways | ||||
| Insulin signaling pathway | ||||
| Glucagon signaling pathway | ||||
| Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
| WikiPathways | Glycogen Metabolism | |||
| Metabolism of carbohydrates | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.